Interleukin-1 acts via the JNK-2 signaling pathway to induce aggrecan degradation by human chondrocytes
<br xmlns:etd="http://www.ouls.ox.ac.uk/ora/modsextensions"><strong>Objective: </strong>Aggrecan enables articular cartilage to bear load and resist compression. Aggrecan loss occurs early in osteoarthritis and rheumatoid arthritis and can be induced by inflammatory cytok...
Autors principals: | Ismail, H, Yamamoto, K, Vincent, T, Nagase, H, Troeberg, L, Saklatvala, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Wiley
2015
|
Ítems similars
-
The interplay between JNK pathway activation, proteoglycan turnover and endocytosis in chondrocytes
per: Ismail, H, et al.
Publicat: (2017) -
JNK2 controls aggrecan degradation in murine articular cartilage and the development of experimental osteoarthritis.
per: Ismail, H, et al.
Publicat: (2015) -
INTERLEUKIN 1 INDUCES AGGRECAN DEGRADATION BY HUMAN ARTICULAR CHONDROCYTES THROUGH A TAK1/MKK4/JNK2 PATHWAY WITHOUT INVOLVEMENT OF NFKB
per: Ismail, H, et al.
Publicat: (2013) -
The c-jun N-terminal kinase (JNK)-2 controls articular cartilage aggrecan degradation and progression of experimental osteoarthritis
per: Ismail, H, et al.
Publicat: (2014) -
Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
per: Durigova, M, et al.
Publicat: (2011)